Wildemeersch P

No ORCID on file · 2 papers in corpus
review 2002
Reproductive biomedicine online ·doi:10.1016/s1472-6483(10)61919-0

A low-dose levonorgestrel (LNG)-releasing intrauterine system (IUS) (FibroPlant) has been clinically developed since 1997 for endometrial suppression during hormone replacement therapy in peri- and postmenopausal women, for the treatment of…

article 2001
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/ejc.6.4.192.198

OBJECTIVES: To evaluate the effect on menstrual pain in women with primary and secondary dysmenorrhea of a novel 'frameless' intrauterine drug delivery system (IUS), FibroPlant-levonorgestrel (LNG) (Contrel Research, Belgium), releasing 14 …